Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2
Olha Puhach, Kenneth Adea, Nicolas Hulo, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1491-1500
Open Access | Times Cited: 323

Showing 1-25 of 323 citing articles:

SARS-CoV-2 viral load and shedding kinetics
Olha Puhach, Benjamin Meyer, Isabella Eckerle
Nature Reviews Microbiology (2022)
Open Access | Times Cited: 302
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
Delphine Planas, Timothée Bruel, Isabelle Staropoli, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 165
Impaired detection of omicron by SARS-CoV-2 rapid antigen tests
Andreas Osterman, Irina Badell, Elif Basara, et al.
Medical Microbiology and Immunology (2022) Vol. 211, Iss. 2-3, pp. 105-117
Open Access | Times Cited: 116
Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study
Seran Hakki, Jie Zhou, Jakob Jonnerby, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 11, pp. 1061-1073
Open Access | Times Cited: 96
Accelerating antiviral drug discovery: lessons from COVID-19
Annette von Delft, Matthew D. Hall, Ann D. Kwong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 585-603
Open Access | Times Cited: 94
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study
James A. Hay, Stephen M Kissler, Joseph R. Fauver, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 90
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
Daniele Focosi, Fabrizio Maggi, Arturo Casadevall
Viruses (2022) Vol. 14, Iss. 2, pp. 187-187
Open Access | Times Cited: 87
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
Marios Koutsakos, Arnold Reynaldi, Wen Shi Lee, et al.
Immunity (2023) Vol. 56, Iss. 4, pp. 879-892.e4
Open Access | Times Cited: 78
Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave
Guanzhu Lu, Yi Zhang, Haocheng Zhang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2045-2054
Open Access | Times Cited: 74
Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
Evropi Amanatidou, Anna Gkiouliava, Eva Pella, et al.
Metabolism Open (2022) Vol. 14, pp. 100180-100180
Open Access | Times Cited: 67
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
Hao Zhou, Michelle Møhlenberg, Jigarji Chaturji Thakor, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 67
Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study
Jie Zhou, Anika Singanayagam, Niluka Goonawardane, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 8, pp. e579-e590
Open Access | Times Cited: 58
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
Devaki Pilapitiya, Adam K. Wheatley, Hyon‐Xhi Tan
EBioMedicine (2023) Vol. 92, pp. 104585-104585
Open Access | Times Cited: 47
SARS‐CoV‐2 in animals: susceptibility of animal species, risk for animal and public health, monitoring, prevention and control
José L. Gonzáles, Denise A. Marston
EFSA Journal (2023) Vol. 21, Iss. 2
Open Access | Times Cited: 45
COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
İlker Polatoğlu, Tülay Öncü Öner, Irem Dalman, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 43
Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants
Emily E. Bendall, Amy P. Callear, Amy Getz, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 41
Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B.1.1.529): a prospective cohort study from Shenzhen, China
Yang Yang, Liping Guo, Jing Yuan, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 8, pp. e632-e641
Open Access | Times Cited: 41
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 38
Role of Fluid Dynamics in Infectious Disease Transmission: Insights from COVID-19 and Other Pathogens
Soumyajit Koley
Trends in Sciences (2024) Vol. 21, Iss. 8, pp. 8287-8287
Open Access | Times Cited: 20
Key Insights into Respiratory Virus Testing: Sensitivity and Clinical Implications
Julio García‐Rodríguez, Frédéric Janvier, Clemens Kill
Microorganisms (2025) Vol. 13, Iss. 1, pp. 63-63
Open Access | Times Cited: 1
Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant
Meriem Bekliz, Kenneth Adea, Olha Puhach, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 65
SARS-CoV-2 Omicron Variant, Lineage BA.1, Is Associated with Lower Viral Load in Nasopharyngeal Samples Compared to Delta Variant
Célia Sentis, Geneviève Billaud, Antonin Bal, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 919-919
Open Access | Times Cited: 58
Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge
John Schrom, Carina Marquez, Genay Pilarowski, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 5, pp. 682-690
Open Access | Times Cited: 57
The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection
Mathias Martins, Gabriela Mansano do Nascimento, Mohammed Nooruzzaman, et al.
Journal of Virology (2022) Vol. 96, Iss. 17
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top